Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Hematologic Recovery from Venetoclax-Containing Regimens in Relapsed/Refractory Acute Myeloid Leukemia Patients Depending on Prior Allogeneic Hematopoietic Cell Transplantation

Rabia Shahswar, MD, Gernot Beutel, MD, Piroska Klement, Alina Rehberg, Razif Gabdoulline, Christian Koenecke, MD, Dominik Markel, MD, Hendrik Eggers, MD, Matthias Eder, MD, Michael Stadler, MD PhD, Lothar Hambach, MD, Steve Ehrlich, MD, Gudrun Gohring, MD, Brigitte Schlegelberger, MD, Arne Trummer, MD, Juergen Krauter, MD, Arnold Ganser, MD, Felicitas Thol, MD, Michael Heuser, MD

Blood (2019) 134 (Supplement_1): 1359.

https://doi.org/10.1182/blood-2019-125377

Published: 2019

Journal Articles

Optimized Induction of Mitochondrial Apoptosis By Combination Therapies with Venetoclax for Chemotherapy-Free Treatment of BCR-ABL + Acute Lymphoblastic Leukemia in Preclinical Models

Matthias Eder, MD, Hanna Kirchhoff, Karin Battmer, Katharina Wohlan, Melanie Ricke-Hoch, PhD, Sergej Erschow, Edward Law, PhD, Arnold Kloos, Michael Heuser, MD, Arnold Ganser, MD, Denise Hilfiker-Kleiner, PhD, Olaf Heidenreich, PhD, Michaela Scherr, PhD

Blood (2018) 132 (Supplement 1): 4025.

https://doi.org/10.1182/blood-2018-99-114463

Published: 2018

Journal Articles

Synergy between FLT3-ITD and p53 Haploinsufficiency or Loss in the Development of Acute Myeloid Leukemia

Zengkai Pan, MD PhD, Min Yang, Kezhi Huang, MD PhD, Guntram Buesche, MD, Gudrun Göhring, MD, Michaela Scherr, PhD, Matthias Gaestel, PhD, Matthias Eder, MD, Julia Skokowa, MDPhD, Jianfeng Zhou, PhD, Karl Welte, Li-Gen Liu, MD, Arnold Ganser, MD, Zhixiong Li, MD

Blood (2018) 132 (Supplement 1): 771.

https://doi.org/10.1182/blood-2018-99-110770

Published: 2018

Journal Articles

The Novel FLT3-N676K Mutant Induces Acute Leukemia Independently of the Inv(16) Chimeric Gene CBFB-MYH11

Kezhi Huang, Min Yang, Zengkai Pan, Florian H. Heidel, MD, Michaela Scherr, PhD, Matthias Eder, MD, Thomas Fischer, MD, Guntram Buesche, MD, Nils von Neuhoff, PhD, Arnold Ganser, MD, Zhixiong Li, MD

Blood (2015) 126 (23): 1383.

https://doi.org/10.1182/blood.V126.23.1383.1383

Published: 2015

Journal Articles

Effective Treatment of Human CML By RNAi In Vivo in a Xenotransplantation Mouse Model

Blood (2015) 126 (23): 1261.

https://doi.org/10.1182/blood.V126.23.1261.1261

Published: 2015

Journal Articles

Impact of Molecular Genetics on Disease-Free Survival in Myelofibrosis Patients Following Allogeneic Stem Cell Transplantation

Blood (2015) 126 (23): 352.

https://doi.org/10.1182/blood.V126.23.352.352

Published: 2015

Journal Articles

Prognostic Impact of Splicing Factor Mutations in Patients with Myelofibrosis Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2014) 124 (21): 3171.

https://doi.org/10.1182/blood.V124.21.3171.3171

Published: 2014

Journal Articles

Prognostic Impact Of a Newly Defined Structurally Complex Karyotype In Patients With AML and MDS After Allogeneic Stem Cell Transplantation

Christiane E Dobbelstein, MD, Elke Dammann, Eva M Weissinger, MD, Michael Stadler, MD, Matthias Eder, MD, Brigitte Schlegelberger, MD, PhD, Arnold Ganser, MD, Gudrun Gohring, MD

Blood (2013) 122 (21): 3362.

https://doi.org/10.1182/blood.V122.21.3362.3362

Published: 2013

Journal Articles

Mir∼17-92 Identifies BCL2 As a Therapeutic Target In BCR-ABL Positive B-Lineage Acute Lymphoblastic Leukemia

Matthias Eder, MD, Alex Elder, David Barzan, Karin Battmer, Simon Bomken, Melanie Ricke-Hoch, Anke Schröder, Letizia Venturini, Heike Pfeiffer, Helen J Blair, PhD, Josef Vormoor, MD, Oliver G. Ottmann, MD, Arnold Ganser, Andreas Pich, Denise Hilfiker-Kleiner, Olaf Heidenreich, PhD, Michaela Scherr

Blood (2013) 122 (21): 835.

https://doi.org/10.1182/blood.V122.21.835.835

Published: 2013

Journal Articles

Function of STAT5 Isoforms in Bcr-Abl Positive Cells

Michael Schaller-Schoenitz, Iris Dallmann, Arnold Ganser, MD, Michaela Scherr, Matthias Eder, MD

Blood (2011) 118 (21): 1313.

https://doi.org/10.1182/blood.V118.21.1313.1313

Published: 2011

Journal Articles

Proteomic Pattern-Based Risk Stratification of Outcome Shows Significant Higher Accuracy Compared to HCT-CI in Patients with AML and MDS,

Christiane E Dobbelstein, MD, Jochen Metzger, Elke Dammann, Uwe Borchert, Stefanie Buchholz, MD, Michael Stadler, MD, Matthias Eder, MD, Juergen Krauter, MD, Arnold Ganser, MD, Eva Mischak-Weissinger, MD

Blood (2011) 118 (21): 4128.

https://doi.org/10.1182/blood.V118.21.4128.4128

Published: 2011

Journal Articles

Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia with Normal Karyotype: A Risk Factor Analysis in 247 Patients, Based On Molecular Markers and Stage at Transplantation.

Blood (2009) 114 (22): 1209.

https://doi.org/10.1182/blood.V114.22.1209.1209

Published: 2009

Journal Articles

Association Between the Hematopoietic Cell Transplantation-Specific Comorbidity Index (CI) and Non-Relapse Mortality (NRM) After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1).

Mohamad Mohty, MD, PhD, Myriam Labopin, Nadezda Basara, Jan J. Cornelissen, MD, PhD, Reza Tabrizi, Claes Malm, M.D., Jose Antonio Pérez Simón, Arnon Nagler, Nicolaus Kroger, Bernard Rio, Rodrigo Martino, MD, Matthias Eder, MD, Karin Bilger, MD, Donald W. Bunjes, MD, PhD, Gérard Socié, MD, Didier Blaise, MD, Emmanuelle Polge, Vanderson Rocha, MDPhD

Blood (2009) 114 (22): 650.

https://doi.org/10.1182/blood.V114.22.650.650

Published: 2009

Journal Articles

Long Term Results of Allogeneic Hematopoietic Cell Transplantation in Elderly Patients.

Michael Stadler, MD, Elke Dammann, Stefanie Buchholz, MD, Bernd Hertenstein, MD, Juergen Krauter, MD, Matthias Eder, MD, Arnold Ganser, MD

Blood (2009) 114 (22): 3388.

https://doi.org/10.1182/blood.V114.22.3388.3388

Published: 2009

Journal Articles

Lineage-Specific Regulation of miRNA-Expression by the BCR-ABL Oncogene.

Michaela Scherr, PhD, Letizia Venturini, PhD, Karin Battmer, Arnold Ganser, MD, PhD, Matthias Eder, MD

Blood (2008) 112 (11): 1084.

https://doi.org/10.1182/blood.V112.11.1084.1084

Published: 2008

Journal Articles

Circulating Angiopoietin-2 Predicts Time to Relapse after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.

Christian Koenecke, MD, Philipp Kümpers, MD, Alexander Lukasz, Hartmut Hecker, MD, Elke Dammann, Willem Verhagen, MD, Sascha David, MD, Gudrun Göhring, MD, Stefanie Buchholz, MD, Eva Weissinger, MD, PhD, Jürgen Krauter, MD, Ph.D., Matthias Eder, MD, Ph.D., Hermann Haller, MD, Ph.D., Arnold Ganser, MD, PhD

Blood (2008) 112 (11): 3259.

https://doi.org/10.1182/blood.V112.11.3259.3259

Published: 2008

Journal Articles

Extramedullary Acute Leukemias prior to and after Allogeneic Hematopoietic Stem Cell Transplantation: a Single Center Study.

Michael Stadler, MD, PhD, Helmut Diedrich, MD, Elke Dammann, Stefanie Buchholz, MD, Eva Mischak-Weissinger, MD, PhD, Juergen Krauter, MD, PhD, Matthias Eder, MD, PhD, Arnold Ganser, MD, PhD

Blood (2008) 112 (11): 3262.

https://doi.org/10.1182/blood.V112.11.3262.3262

Published: 2008

Journal Articles

Lower Relapse Incidence and Relapse Mortality in Patients Transplanted from a Younger Sibling in HLA-Identical Stem Cell Transplantation: Does Microchimerism Matter?

Christiane Dobbelstein, MD, Haytham Kamal, MD, Elke Dammann, Eva Mischak-Weissinger, MD, PhD, Michael Stadler, MD, PhD, Juergen Krauter, MD, PhD, Arnold Ganser, MD, PhD, Matthias Eder, MD, PhD

Blood (2008) 112 (11): 343.

https://doi.org/10.1182/blood.V112.11.343.343

Published: 2008

Journal Articles

Improved Outcome for Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) with Poor Risk Cytogenetics – Result from An Analysis on 172 Patients Receiving FLAMSA-RIC Conditioning for Allogeneic Stem Cell Transplantatioin (SCT).

Blood (2008) 112 (11): 1971.

https://doi.org/10.1182/blood.V112.11.1971.1971

Published: 2008

NARROW

Hematologic Recovery from Venetoclax-Containing Regimens in Relapsed/Refractory Acute Myeloid Leukemia Patients Depending on Prior Allogeneic Hematopoietic Cell Transplantation

Optimized Induction of Mitochondrial Apoptosis By Combination Therapies with Venetoclax for Chemotherapy-Free Treatment of BCR-ABL + Acute Lymphoblastic Leukemia in Preclinical Models

Synergy between FLT3-ITD and p53 Haploinsufficiency or Loss in the Development of Acute Myeloid Leukemia

The Novel FLT3-N676K Mutant Induces Acute Leukemia Independently of the Inv(16) Chimeric Gene CBFB-MYH11

Effective Treatment of Human CML By RNAi In Vivo in a Xenotransplantation Mouse Model

Impact of Molecular Genetics on Disease-Free Survival in Myelofibrosis Patients Following Allogeneic Stem Cell Transplantation

Prognostic Impact of Splicing Factor Mutations in Patients with Myelofibrosis Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Prognostic Impact Of a Newly Defined Structurally Complex Karyotype In Patients With AML and MDS After Allogeneic Stem Cell Transplantation

Genetic Characterization Of Aplastic Anemia Patients By Targeted Sequencing

Mir∼17-92 Identifies BCL2 As a Therapeutic Target In BCR-ABL Positive B-Lineage Acute Lymphoblastic Leukemia

Function of STAT5 Isoforms in Bcr-Abl Positive Cells

Proteomic Pattern-Based Risk Stratification of Outcome Shows Significant Higher Accuracy Compared to HCT-CI in Patients with AML and MDS,

Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia with Normal Karyotype: A Risk Factor Analysis in 247 Patients, Based On Molecular Markers and Stage at Transplantation.

Association Between the Hematopoietic Cell Transplantation-Specific Comorbidity Index (CI) and Non-Relapse Mortality (NRM) After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1).

Long Term Results of Allogeneic Hematopoietic Cell Transplantation in Elderly Patients.

Lineage-Specific Regulation of miRNA-Expression by the BCR-ABL Oncogene.

Circulating Angiopoietin-2 Predicts Time to Relapse after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.

Extramedullary Acute Leukemias prior to and after Allogeneic Hematopoietic Stem Cell Transplantation: a Single Center Study.

Lower Relapse Incidence and Relapse Mortality in Patients Transplanted from a Younger Sibling in HLA-Identical Stem Cell Transplantation: Does Microchimerism Matter?

Improved Outcome for Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) with Poor Risk Cytogenetics – Result from An Analysis on 172 Patients Receiving FLAMSA-RIC Conditioning for Allogeneic Stem Cell Transplantatioin (SCT).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only